What to expect in this section:
Ask Permission before Treatment of Obesity
Employing an empathetic approach
The complex and sensitive nature of obesity can make conversations difficult to have with patients. An empathetic approach and asking permission is a helpful starting point. Results from The Awareness, Care and Treatment in Obesity MaNagement – an International Observation (ACTION IO) Study* showed that 2/3 of people living with obesity would like their healthcare professional to bring up their weight.1
Research indicates that when healthcare professionals employ an empathetic approach and other techniques consistent with motivational interviewing, patients are more likely to attempt weight loss through changes in eating and activity habits.2
When opening the conversation it’s important to ask for permission as talking about weight may be a sensitive topic.1,3
Once you have permission to discuss weight, ensure you use positive, motivational and patient-first language at all times.4 Below are two examples of how to discuss obesity with your patient, one is best practice and the other is language you should avoid.4
If a patient does not give permission and doesn’t want to have a discussion about their weight, do not push it further and inform them that you will be available to discuss in the future if they change their mind.3
Health risks associated with obesity
As you initiate the conversation with your patient with obesity, it is recommended to advise about the health risks associated with obesity.3
To balance the discussion of health risks associated with excess weight, consider advising your patient on how a weight loss of 5% has significant health benefits, and a sustained weight loss of 10-15% or more can further enhance these benefits and provide additional improvements to health.5-11
Below are some talking points and questions:
For more information on obesity-related complications, click here.
*The Awareness, Care and Treatment in Obesity MaNagement – an International Observation (ACTION IO) Study is the first international study to investigate barriers to obesity management among people with obesity and healthcare professionals in 11 countries worldwide. A total of 14,502 people with obesity and 2,785 healthcare professionals completed the survey.1
1. Caterson I, Alfadda A, Auerbach P, et al. Gaps to bridge: misalignment between perception, reality and actions in obesity. Diabetes Obes Metab. 2019:21:1914–1924.
2. Pollak K, Ostby T, Alexander S, et al. Empathy goes a long way in weight loss discussions. J Fam Pract. 2007;56:1031–1036.
3. Vallis M, Piccinini-Vallis H, Sharma A, et al. Modified 5As. Canadian Family Physician. 2013; 59:27–31.
4. Wadden T and Didie E. What’s in a Name? Patients’ Preferred Terms for Describing Obesity. Obesity Research. 2003;11:1140–1146.
5. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
6. Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481–1486.
7. Dattilo AM and Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320–328.
8. Coggon D, Reading I, Croft P et al. Knee
osteoarthritis and obesity. Intl J Obesy.
9. Christensen R, Bartels EM, Astrup A, et al. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2007;66:433–439.
10. Zelber-Sagi S, Godos J and FS. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therap Adv Gastroenterol. 2016;9:392–407.
11. Glass LM, Dickson RC, Anderson JC, et al. Total body weight loss of >/= 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis. Dig Dis Sci. 2015;60:1024–1030.
12. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529.
13. Seagle H, Witt Strain G, Makris A, et al. Position of the American Dietetic Association: weight management. J AM Diet Assoc. 2009;109:330–346.
HQ20OB00137, Approval date: December 2020
You are leaving RethinkObesity.Global
The site you are entering is not the property of, nor managed by, Novo Nordisk. Novo Nordisk assumes no responsibility for the content of sites not managed by Novo Nordisk. Furthermore, Novo Nordisk is not responsible for, nor does it have control over, the privacy policies of these sites.